AbbVie Inc (NYSE:ABBV) has announced that it has signed an agreement with Samsung Bioepis plus its joint venture Biogen Inc (NASDAQ:BIIB) that will help reduce competition for their biosimilar version so as to boost Humira until 2023. This is the second agreement that the company has signed over the years...
Commenting on plans for 2017, Marinus Pharmaceuticals Inc (NASDAQ:MRNS) reported that the company plans to commence Phase 2 study in women with PPD in the first half of 2017. The top-line report from patients with genetic, orphan disorders is expected to come in mid-2017. It also plans to commence...
Dallas, Texas 03/20/2014 (FINANCIALSTRENDS) –  Array Biopharma Inc (NASDAQ:ARRY), a bio-pharmaceutical company, recently revealed results from a Phase-II trial of ARRY-502 in patients suffering from Th2-Driven Asthma. The data was revealed at the 2014 American Academy Of Allergy, Asthma & Immunology (AAAAI) Annual Meeting. According to the company's data, the oral CRTh2...
The US oncology company, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) is under investigation by WeissLaw LLP due to infringement of the legal duty of a fiduciary by the board of directors of the company, which is in link with the recent acquisition by Takeda Pharmaceuticals  Company Limited. Takeda stated as on 9 January 2017 that,...
Novavax, Inc. (NASDAQ:NVAX) has promoted Dr. James F. Cummings to VP, Clinical Development & Translational Medicine role with the company. Dr. Cummings had joined company as Senior Director of Clinical Development in 2015, with a key focus on developing company’s programs within growing infectious disease. The buzz Prior to that, Dr....
In the last trading session, the stock price of Infinity Pharmaceuticals Inc (NASDAQ:INFI) declined more than 1% to close the day at $1.80. The decline came at a share volume of 967,480 compared to average share volume of 2.2 million. Last month, the firm posted Phase 1 translational and...
Dallas, Texas 10/07/2013 (Financialstrend) - Market value of drug development company stock Venaxis Inc (NASDAQ:APPY) has swung like pendulum over the past 30 days. During 15 days period of September 5 to September 15 the shares appreciated by close to 27%. Since then the stock has seen an appreciable drop...
Dallas, Texas 11/21/2013 (Financialstrend) - In Wednesday’s trading session, Cell Therapeutics Inc (NASDAQ:CTIC) rose by 3.70%. The opening price of the shares was $1.93, which climbed to an intraday high of $1.98 and headed to close at $1.96. Around 3.55 million shares were exchanged on Wednesday while the average-volume of...
Cerulean Pharma Inc (NASDAQ:CERU) a clinical-stage firm advancing nanoparticle-drug conjugates reported that its Board of Directors is performing a comprehensive assessment of strategic options focused on increasing stockholder value. The company has engaged Aquilo Partners, L.P. as its financial advisor to help in the strategic review process. The details The objective...
Dallas, Texas 08/05/2013 (Financialstrend) - Rite Aid Corporation (NYSE:RAD) which was witnessing the downfall in the sales persistently is trailing the two major companies namely Walgreen Company and CVS Caremark Corporation with regards to the count of stores. This downward trend in the sales was faced by Rite Aid Corporation...